USFDA gives Zero Observations to SMS Lifesciences

The inspection commenced on 04.04.2022 and concluded on 08.04.2022.

417
USFDA Inspection
USFDA Inspection

Last Updated on October 14, 2024 by The Health Master

Telangana: SMS Lifesciences India has recently announced that the United States Food and Drug Administration (USFDA) has concluded an inspection with zero observations at its API’s manufacturing facility located at Kazipally, Jinnaram MandaI, Sangareddy district, Telangana (Unit I ).

“We are glad to inform you that the Company has completed the United States Food and Drug Administration (USFDA) inspection at its API’ s manufacturing facility located at Sy. NO.180/2, Kazipally, Jinnaram MandaI, Sangareddy district, Telangana (Unit I ), without any observations,” the company said in a BSE filing.

The inspection commenced on 04.04.2022 and concluded on 08.04.2022.

SMS Lifesciences is a global player in APIs / Intermediates manufacturing having a research and manufacturing team supported by state-of-the-art facilities.

What started off as a single facility – single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments. SMS Group was given the export house status in the year 1997-98.

Having three multi-product facilities in operation and a research centre, SMS Lifesciences executed contract manufacturing and research assignment for the global customer base.

The company has won accolades like the “India Pharma Bulk Drug Company of the Year Award” from the Government of India in 2020 and the “Outstanding Export Performance Award 2018-19” in the “All round-Rising Star” Category from The Pharmaceuticals Export Promotion Council of India.

USFDA issues 4 Observations to Lupin for Tarapur Facility

USFDA gives 13 observations to Lupin

USFDA complete audit of Granules Pharmaceuticals with 3 observations

USFDA issues 3 observations on Zydus manufacturing unit

USFDA issues 3 observations to Granules Pharmaceuticals Inc

USFDA completes audit at MSN Pharma with zero observations

NPPA fixes ceiling price of these two vaccines

Online दवा बिक्री पर रोक लगाए सरकार, CAIT ने लगाई मंत्रियों से गुहार: Must read

After Cosmetics and Blood, now scientists detect microplastics in Lungs

CDSCO gives nod to Mylan to import and market Liposomal Amphotericin…

Indian Ophthalmic Manufacturers stress on importance of USFDA norms

42% of samples detected with prima facie violation of DPCO: Govt

USFDA gives nod to Indoco Remedies for Lacosamide injection

USFDA gives tentative approval to Alembic for generic Pradaxa capsules

Track and trace system implementation for export of drugs extended

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news